Stem Cell-derived Nanoparticles Modulate Immune Cells and Help Delay Type 1 Diabetes in Mice, UCLA Study Finds
November 19, 2026
November 19, 2026
LOS ANGELES, California, Nov. 19 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Stem cell-derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice, UCLA study finds
The experimental approach of locally delivering nanoparticles calms harmful immune activity, helping protect insulin-producing cells
November 18, 2026
Key Takeaways
* UCLA researchers found that extracellular . . .
* * *
Stem cell-derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice, UCLA study finds
The experimental approach of locally delivering nanoparticles calms harmful immune activity, helping protect insulin-producing cells
November 18, 2026
Key Takeaways
* UCLA researchers found that extracellular . . .
